Skip to content
Subscribe
Newsletter
Advertise
MDA.org
Donate
Subscribe
Donate
Menu
Magazine
Current Issue
Past Issues
Featured Content
Topics
Advocacy
Finding a Diagnosis
Get Involved
Health
Inclusion
Independence
Lifestyle
News
Personal Stories
Science + Research
Diseases A-Z
Blog
Podcast
Product Guide
Career Quest
Research
Blog Post
MDA Awards Venture Philanthropy Grant to AcuraStem to Develop Treatment for ALS
By
Jeanene Swanson
|
January 15, 2019
Blog Post
Newborn Screening for DMD and BMD: MDA Needs Your Help
By
MDA Staff
|
January 15, 2019
Blog Post
Clinical Trial Alert: Orphazyme Seeks Participants for a Phase 3 ALS Study
By
MDA Staff
|
January 11, 2019
Blog Post
Clinical Trial Alert: Catabasis Seeks Participants for a Phase 3 DMD Study
By
MDA Staff
|
January 10, 2019
Blog Post
Wave Life Sciences Announces Phase 2/3 Duchenne Muscular Dystrophy Clinical Trial of Suvodirsen (WVE-210201) Selected for FDA Complex Innovative Trial Designs Pilot Program
By
Jeanene Swanson
|
January 8, 2019
Blog Post
FDA Grants Orphan Drug Designation to Myonexus Therapeutics’ MYO-102 Gene Therapy Drug for Limb-Girdle Muscular Dystrophy Type 2D
By
Jeanene Swanson
|
January 4, 2019
Blog Post
C9ORF72 Mutation Most Common Cause of Familial ALS, FTD, ALS-FTD
By
Amy Madsen
|
September 20, 2011
Blog Post
National ALS Registry Now Open
By
Miriam Davidson
|
October 19, 2010
Featured Article
ALS Research Poison Dirt
By
Margaret Wahl
|
December 8, 2009
Blog Post
Water-Contamination Link to ALS Tenuous Without More Data
By
Margaret Wahl
|
June 30, 2009
« Previous
1
…
23
24
25
26
Next »
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset